With mesenteric adipose tissue better poised to influence the development of metabolic syndrome, it is not surprising that of the two adipose depots, chemerin would play a larger role in the adipocyte development of the mesenteric, rather than the retroperitoneal, fat. This evidence concerns the gene RARRES2 and metabolic syndrome.